News & Updates
Filter by Specialty:
Long-term tolvaptan cost-effective only in CHF patients needing high-dose furosemide
07 Feb 2022
While tolvaptan does not seem to provide a clear economic benefit in all patients with chronic heart failure (CHF), its use in those who require high-dose furosemide may be cost-effective, a recent study has found.